Related Experiment Video
Updated: Aug 8, 2026

X-Ray Visualization of Intraductal Ethanol-Based Ablative Treatment for Prevention of Breast Cancer in Rat Models
Published on: December 9, 2022
[Prolactin in connective tissue diseases]
Jolanta Parada-Turska1, Bozena Targońska-Stepniak, Maria Majdan
1Katedra i Klinika Reumatologii i Układowych Chorób Tkanki Łacznej Akademii Medycznej im. prof. Feliksa Skubiszewskiego w Lublinie.
Abstract:
This paper presents interactions between prolactin (PRL) and the immune system. We describe the role of PRL in the pathogenesis of rheumatic diseases, particularly connective tissue diseases, including systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), primary Sjögren's syndrome, systemic sclerosis, polymyalgia rheumatica, and seronegative arthritis. We present current opinion on the mechanisms responsible for hyperprolactinemia in SLE patients and the association between hyperprolactinemia and SLE activity and organ involvement. The role of dopamine receptor agonists in the treatment of connective tissue diseases is discussed.
Related Concept Videos
Connective Tissue Cell Types
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
Extracellular Matrix
Functions of Connective Tissues
Hard connective tissues, such as bones and cartilage, provide structure and support to the body.
Type IV Collagen of Basal Lamina
A type IV collagen molecule has six alpha chains which can exist in...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Chronic Inflammation: Introduction
